| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
-1 |
| Equity
Latest Equity |
30.87 |
| Face Value
Latest Face Value |
10 |
| Reserves
Total Reserve |
135.53 |
| Dividend
Full Year Dividend % |
0 |
| Sales Turnover
Full Year Net Sales |
472.27 |
| Net Profit
Full Year Net Profit |
3.97 |
| Full Year CPS
Full Year Cash Per Share |
2.2 |
| Earning Per Share
Full Year Earning Per Share |
1.3 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Jun 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
44.63 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
53.9 |
| Networth
Full Year Return on Networth |
2.96 |
| Price/Book Value
Price to Book value |
1.762523 |
| Yearly PE ratio
Full Year Price to Earning per share |
73.9 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
43 |
| Bse value
BSE Value in lakhs |
11.29 |
| Nse value
NSE Value in lakhs |
104.31 |
| High
52 week high |
100 |
| Low
52 week low |
50 |
| Price
NSE Current market price |
96 |
| CPM
Current market price |
95 |
| Market cap
BSE / NSE Market Cap |
293.4 |
| Net profit
Latest Quarter Net Profit |
1.02 |
| Net profit variance
Latest Quarter Net Profit variance |
-25 |
| Result year
Trailing latest month |
Jun 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
518.89 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
6.17 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
1.19 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
7.42 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
1.79 |
| TTM NP
Trailing Twelve 12 month Net Profit |
6.9 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
0.45 |
| TTM EPS
Trailing Twelve 12 month EPS |
1.35 |
| TTM PE
Trailing Twelve 12 month PE |
70.39 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
4.68 |
| Equity
Latest Equity |
30.87 |
| LTP
Latest Price (BSE/NSE) |
95 |
| Gross block
Latest Gross Block |
39.1 |
| Loans
Total loans |
1.13 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
1.5 |
| Year GPM
Full Year Gross Profit Margin |
1.8 |
| Quarter OPM
Latest quater Operation Profit Margin |
3 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 105 | 134 | 108 | 102 | 84 | 96 | 189 | 45 |
| YOY Sales Growth % | 82% | 75% | -49% | -19% | -20% | -28% | 75% | -56% |
| Gross Sales | 105 | 134 | 108 | 102 | 84 | 96 | 189 | 45 |
| + Expenses | 101 | 132 | 112 | 101 | 82 | 98 | 185 | 43 |
| Material Cost % | 101% | 99% | 128% | 86% | 92% | 106% | 95% | 100% |
| Raw Material Cost | 103 | 131 | 124 | 93 | 79 | 99 | 179 | 43 |
| Change in Inventory | 4 | 1 | 15 | -5 | -2 | 3 | 0 | 1 |
| Manufacturing Cost % | 1% | 1% | 1% | 2% | 1% | 1% | 1% | 1% |
| Employee Cost % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Other Cost % | -6% | -1% | -26% | 10% | 4% | -5% | 2% | -5% |
| Raw Materials % | 98% | 98% | 114% | 91% | 94% | 103% | 95% | 97% |
| Stock Adjustments % | -3% | -1% | -13% | 5% | 2% | -3% | 0% | -3% |
| Other Manufacturing Expenses % | 1% | 1% | 1% | 2% | 1% | 1% | 1% | 1% |
| Selling & Administration % | 1% | 0% | 1% | 1% | 0% | 0% | 2% | 1% |
| Operating Profit | 4 | 2 | -4 | 2 | 3 | -2 | 4 | 1 |
| OPM % | 4% | 2% | -4% | 2% | 3% | -2% | 2% | 3% |
| + Other Income | 0 | 1 | 8 | 2 | 1 | 4 | 0 | 2 |
| Miscellaneous Income | 0 | 1 | 8 | 2 | 1 | 4 | 0 | 2 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 2 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 |
| + Tax % | 9% | 49% | 71% | 21% | 31% | 38% | -22% | -98% |
| Current Tax | 0 | 0 | 1 | 0 | 0 | 0 | -1 | 0 |
| Deferred Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Profit | 2 | 1 | 0 | 1 | 1 | 1 | 2 | 1 |
| EPS in Rs |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Sales | 246 | 396 | 349 | 355 | 300 | 348 | 493 | 419 | 396 | 474 |
| Sales Growth % | 61% | -12% | 2% | -15% | 16% | 41% | -15% | -6% | 20% | |
| Gross Sales | 246 | 396 | 349 | 355 | 300 | 348 | 493 | 420 | 396 | 474 |
| + Expenses | 245 | 386 | 342 | 347 | 297 | 344 | 481 | 411 | 391 | 471 |
| Material Cost % | 99% | 97% | 97% | 96% | 97% | 96% | 95% | 96% | 97% | 97% |
| Raw Material Cost | 241 | 386 | 347 | 347 | 286 | 336 | 461 | 419 | 388 | 473 |
| Change in Inventory | 2 | -3 | -10 | -6 | 4 | -1 | 5 | -15 | -6 | -11 |
| Manufacturing Cost % | 0% | 0% | 0% | 0% | 0% | 1% | 2% | 0% | 0% | 0% |
| Employee Cost % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Other Cost % | 1% | 1% | 1% | 1% | 2% | 1% | 1% | 1% | 2% | 1% |
| Raw Materials % | 98% | 98% | 99% | 98% | 95% | 96% | 94% | 100% | 98% | 100% |
| Stock Adjustments % | -1% | 1% | 3% | 2% | -1% | 0% | -1% | 4% | 1% | 2% |
| Power & Fuel % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Other Manufacturing Expenses % | 0% | 0% | 0% | 0% | 0% | 1% | 2% | 0% | 0% | 0% |
| Selling & Administration % | 1% | 1% | 1% | 1% | 2% | 1% | 1% | 1% | 2% | 1% |
| Miscellaneous Expenses % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Operating Profit | 1 | 10 | 8 | 8 | 3 | 5 | 11 | 8 | 4 | 3 |
| OPM % | 0% | 2% | 2% | 2% | 1% | 1% | 2% | 2% | 1% | 1% |
| + Other Income | 3 | 3 | 3 | 4 | 7 | 7 | 3 | 3 | 7 | 10 |
| Miscellaneous Income | 3 | 3 | 3 | 4 | 7 | 7 | 3 | 1 | 7 | 10 |
| Interest | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 5 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 2 | 8 | 8 | 9 | 7 | 8 | 10 | 6 | 5 | 6 |
| + Tax % | 29% | 31% | 25% | 27% | 20% | 21% | 35% | 37% | 12% | 34% |
| Current Tax | 1 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 1 | 2 |
| Deferred Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| + Net Profit | 1 | 6 | 6 | 7 | 6 | 6 | 7 | 4 | 5 | 4 |
| Profit Growth % | 355% | 5% | 6% | -11% | 9% | 3% | -35% | 20% | -21% | |
| EPS in Rs |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 18 | 23 | 23 | 23 | 23 | 25 | 25 | 28 | 28 |
| Reserves | 20 | 31 | 57 | 63 | 69 | 75 | 88 | 90 | 102 | 108 |
| + Borrowings | 15 | 10 | 3 | 16 | 18 | 18 | 14 | 38 | 31 | 35 |
| Secured Borrowings | 15 | 10 | 3 | 16 | 17 | 0 | 0 | 4 | 30 | 34 |
| Unsecured Borrowings | 0 | 0 | 0 | 0 | 1 | 18 | 14 | 33 | 1 | 1 |
| Deferred Credit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Other Liabilities | 74 | 83 | 86 | 43 | 84 | 116 | 117 | 139 | 142 | 120 |
| Current Liabilities | 74 | 83 | 86 | 43 | 84 | 114 | 117 | 136 | 140 | 117 |
| Provisions | 1 | 2 | 3 | 4 | 3 | 2 | 5 | 5 | 4 | 4 |
| Equity Share Warrants | 0 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 3 |
| Other liability items | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
| Total Liabilities | 125 | 143 | 170 | 146 | 194 | 233 | 245 | 291 | 303 | 291 |
| + Fixed Assets | 8 | 12 | 12 | 12 | 12 | 14 | 14 | 14 | 13 | 16 |
| Gross Block | 19 | 24 | 25 | 26 | 26 | 30 | 32 | 33 | 34 | 39 |
| Accumulated Depreciation | 12 | 12 | 13 | 14 | 14 | 16 | 18 | 19 | 21 | 23 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| + Other Assets | 117 | 130 | 157 | 133 | 181 | 218 | 230 | 277 | 289 | 272 |
| Inventories | 2 | 5 | 15 | 21 | 17 | 18 | 14 | 29 | 35 | 45 |
| Trade receivables | 72 | 82 | 95 | 106 | 96 | 162 | 136 | 190 | 184 | 133 |
| Cash Equivalents | 2 | 1 | 3 | 0 | 1 | 1 | 0 | 1 | 2 | 1 |
| Loans n Advances | 41 | 42 | 44 | 6 | 68 | 37 | 76 | 51 | 63 | 85 |
| Other asset items | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 6 | 6 | 7 |
| Total Assets | 125 | 143 | 170 | 146 | 194 | 233 | 245 | 291 | 303 | 291 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 6 | 1 | -20 | 1 | 3 | 5 | -4 | -1 | -3 | 10 |
| Profit Before Tax & Extraordinary Items | 2 | 8 | 8 | 9 | 7 | 8 | 10 | 6 | 5 | 6 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Interest (Net) | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 5 |
| Provisions & Write-offs (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | -6 | -9 | -13 | -10 | 10 | -66 | 26 | -54 | 5 | 51 |
| Inventories | 2 | -3 | -10 | -6 | 4 | -1 | 5 | -15 | -6 | -11 |
| Trade Payables | 5 | 3 | 3 | -40 | 40 | 33 | -1 | 18 | 2 | -26 |
| Loans & Advances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9 | -7 | -14 |
| Change in Borrowing | 3 | -4 | -7 | 13 | 2 | 0 | -8 | 23 | -5 | 5 |
| Direct Taxes Paid | 0 | -2 | -3 | -2 | -2 | -2 | -4 | -2 | -1 | -2 |
| + Cash from Investing Activity | -3 | -5 | -1 | -1 | -1 | -3 | -2 | 0 | -2 | -6 |
| Purchase of Fixed Assets | -3 | -5 | -1 | -1 | -1 | -3 | -2 | -1 | -1 | -5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | -1 |
| + Cash from Financing Activity | -2 | 4 | 23 | -2 | -2 | -2 | 6 | 1 | 6 | -4 |
| Proceeds from Issue of Shares | 0 | 7 | 24 | 0 | 0 | 0 | 8 | 0 | 11 | 2 |
| Proceeds from Other Long-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 |
| Share Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Long-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -2 |
| Dividend Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Net Cash Flow | 1 | -1 | 2 | -3 | 0 | 0 | 0 | 1 | 1 | 0 |